Table 3.

Unadjusted and adjusted prevalence ratios (PR) for ever use of emergency contraception since cancer diagnosis among cancer survivors (n=616)

	Unadjusted PR (95% CI)	p-value	Adjusted PR (95% CI)	p-value
Race
Non-white	1.4 (1.1–1.9)	0.02	1.3 (1.0–1.7)	0.05
White	Reference		Reference
Current age
18–24	1.3 (0.8–2.4)	0.31	0.9 (0.5–1.6)	0.71
25–30	1.7 (1.2–2.3)	0.001	1.4 (1.0–1.9)	0.06
31–35	Reference	-	Reference	-
36–40	0.7 (0.5–1.0)	0.06	0.7 (0.5–1.0)	0.05
Breast cancer diagnosis	0.5 (0.3–0.7)	<0.001	0.6 (0.4–1.0)	0.04
Other cancer diagnosis	Reference		Reference
Chemotherapy	0.8 (0.6–1.0)	0.05	0.8 (0.6–1.0)	0.09
No chemotherapy	Reference		Reference
Partnered relationship	0.5 (0.4–0.7)	<0.001	0.6 (0.5–0.9)	0.003
Not partnered	Reference		Reference
Ever live birth	0.6 (0.5–0.9)	0.003	0.9 (0.7–1.3)	0.67
Never live birth	Reference		Reference